2022
DOI: 10.3390/v14030454
|View full text |Cite
|
Sign up to set email alerts
|

Analyses of Long-Term Epidemic Trends and Evolution Characteristics of Haplotype Subtypes Reveal the Dynamic Selection on SARS-CoV-2

Abstract: The scale of SARS-CoV-2 infection and death is so enormous that further study of the molecular and evolutionary characteristics of SARS-CoV-2 will help us better understand and respond to SARS-CoV-2 outbreaks. The present study analyzed the epidemic and evolutionary characteristics of haplotype subtypes or regions based on 1.8 million high-quality SARS-CoV-2 genomic data. The estimated ratio of the rates of non-synonymous to synonymous changes (Ka/Ks) in North America and the United States were always more tha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 39 publications
(61 reference statements)
0
1
0
Order By: Relevance
“…Based on our previous research on the evolution of SARS-CoV-2 consensus genomes ( 28 - 31 ), we investigated the characteristics of SARS-CoV-2 within-host diversity and the implications of iSNVs for viral immune evasion using almost 2,00,000 raw genome sequencing data of SARS-CoV-2. Our work provided insights into the possible mutation drivers or their mutational signatures for iSNVs and the evolutionary strategies of SARS-CoV-2 to escape human innate and adaptive immunity.…”
Section: Introductionmentioning
confidence: 99%
“…Based on our previous research on the evolution of SARS-CoV-2 consensus genomes ( 28 - 31 ), we investigated the characteristics of SARS-CoV-2 within-host diversity and the implications of iSNVs for viral immune evasion using almost 2,00,000 raw genome sequencing data of SARS-CoV-2. Our work provided insights into the possible mutation drivers or their mutational signatures for iSNVs and the evolutionary strategies of SARS-CoV-2 to escape human innate and adaptive immunity.…”
Section: Introductionmentioning
confidence: 99%